YSPSL for Prevention of Delayed Graft Function Part A

NCT00298181 · clinicaltrials.gov ↗

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Delayed Graft Function

Interventions

DRUG: YSPSL

Sponsor

Y's Therapeutics, Inc.